Global Tranexamic Acid Market Growth 2023-2029

Global Tranexamic Acid Market Growth 2023-2029

Tranexamic acid is a synthetic amino acid. Other names include hemolytic inflammation, hemostatic acid, tranexamic acid, etc. It has the pharmacological effect of stopping bleeding and anti-inflammatory. It is used as a blood coagulation agent, and it has two kinds of injections and oral administration.

LPI (LP Information)' newest research report, the “Tranexamic Acid Industry Forecast” looks at past sales and reviews total world Tranexamic Acid sales in 2022, providing a comprehensive analysis by region and market sector of projected Tranexamic Acid sales for 2023 through 2029. With Tranexamic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tranexamic Acid industry.

This Insight Report provides a comprehensive analysis of the global Tranexamic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tranexamic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tranexamic Acid market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tranexamic Acid and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tranexamic Acid.

The global Tranexamic Acid market size is projected to grow from US$ 80 million in 2022 to US$ 100 million in 2029; it is expected to grow at a CAGR of 100 from 2023 to 2029.

Main manufacturers of tranexamic acid in global market are Venkata Sai Life Sciences, Aquatic Remedies and Taicang Pharmaceutical Factory. In terms of application, surgery and trauma holds over 40% of market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Tranexamic Acid market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
USP25
BP2000
Others

Segmentation by application
Trauma
Craniocerebral Trauma
Menorrhagia
Postpartum Hemorrhage
Surgery
Whitening Cosmetics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Venkata Sai Life Sciences
Aquatic Remedies
Taicang Pharmaceutical Factory
Shilpa Medicare Limited
Yangtze River Pharmaceutical Group
Dongting Pharma
Huluwa Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tranexamic Acid market?

What factors are driving Tranexamic Acid market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tranexamic Acid market opportunities vary by end market size?

How does Tranexamic Acid break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.